Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00589641 · ClinicalTrials.gov registry record · Phase 1
Relapse Prevention for Suicidal Dually Diagnosed Youths
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 13
- Enrollment target
NCT00589641 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 13 participants.
The verdict
NCT00589641, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to develop, refine, and pilot test an augmenting cognitive behavior relapse prevention intervention (CBT-RP) for suicidal, depressed, and alcohol/substance abusing adolescents. No hypotheses are being tested, but it is expected that CBT-RP in addition to treatment as usual will result in improved outcomes relative to treatment as usual alone.
Interventions
- BEHAVIORAL CBT-RP (relapse prevention) + Enhanced TAU
- BEHAVIORAL Enhanced TAU Alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2005-07 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00589641
The ClinicalTrials.gov registry entry for NCT00589641 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CBT-RP (relapse prevention) + Enhanced TAU is the first listed.
NCT00589641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00589641 about?
NCT00589641 is a clinical study titled "Relapse Prevention for Suicidal Dually Diagnosed Youths". The purpose of this study is to develop, refine, and pilot test an augmenting cognitive behavior relapse prevention intervention (CBT-RP) for suicidal, depressed, and alcohol/substance abusing adolescents. No hypotheses are being tested, but it is expected that CBT-RP in addition to treatment as usu...
What is the current status of trial NCT00589641?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 13 participants. The study started on 2005-07. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00589641?
The interventions under investigation include: CBT-RP (relapse prevention) + Enhanced TAU (BEHAVIORAL), Enhanced TAU Alone (BEHAVIORAL).
Who is sponsoring clinical trial NCT00589641?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.